Introduction
Sepsis is one of the main causes of death in noncoronary intensive care units and, despite advances in the understanding of its pathophysiology, epidemiology, and treatment, the mortality rate remains high (1) . A systemic inflammatory response involving multiple endogenous mediators is deflagrated, causing tissues and organ damage (2) . The systemic release of free radicals leads to a compromised vascular response and endothelial dysfunction (3) .
Vascular dysfunction characterized by compromised vasoconstriction and vasodilatation functions aggravates organ perfusion, leading to a vicious cycle of more tissue damage. Endothelial dysfunction in vascular disease states is associated with reduced nitric oxide (NO) bioactivity. Endothelial NO synthase (eNOS) uncoupling, whereby eNOS generates O 2
•-rather than NO, is a mechanism underlying endothelial dysfunction (4). Brandes et al. (5) reported increased production of superoxide and hydrogen peroxide by vascular rings of rats treated with lipopolysaccharide (LPS), mainly by endothelial cells. Javesghani et al. (6) recently reported in addition an increase in peroxynitrite generation after LPS injection. These data suggest that some of the toxic effects of superoxide in sepsis may actually be caused by peroxynitrite (7) . In addition, sepsis induces endothelial activation (8) with release of ATP and ADP from platelets and vasculature (9) . ATP and ADP are released by cell lysis, selective permeabilization of the plasma membrane and secretion from platelet dense bodies in response to specific mediators (10) (11) (12) (13) potential to modulate endothelial cells, platelet activation, leukocyte migration, and cytokine release (14) . NO has been reported to regulate the mitochondrial respiratory cascade and to increase superoxide production with a lower production of ATP, an important event in sepsis (15, 16) . At the same time, oxidative stress activates poly(ADP-ribose) polymerase that consumes ATP (17) . ATP has been reported to modulate the vascular release of NO under physiological conditions (18) and to modulate the release of superoxide in macrophages (19, 20) as well as inflammatory mediators by the autonomic system (21) . The effect of ATP on vascular and endothelial function in sepsis has not been studied. We present data showing that ATP increased vascular relaxation in septic rings, an important fact from a clinical viewpoint. Therefore, we hypothesized that ATP is able to repair endothelial dysfunction. In order to attempt to understand this process, we determined the actions of ATP on vascular function during sepsis in terms of vascular reactivity and their correlation with superoxide and NO production and eNOS phosphorylation.
Material and Methods
The Ethics Committee for Analysis of Research Projects (CAPPesq) approved the present in vivo study, which was conducted according to CAPPesq guidelines and according to the Guide for the Care and Use of Laboratory Animals adopted and promulgated by the U.S. National Institutes of Health.
Experimental protocol
Forty male Wistar rats weighing 240-260 g were randomly assigned to 2 groups: one group received 10 mg/kg, ip, LPS (Escherichia coli serotype 026:B6) and the other received saline ip. Animals were sacrificed 16 h after LPS or vehicle injection.
Aorta preparation
The aorta preparation was the same for the experiments of vascular superoxide generation and vascular reactivity. The thoracic aortas were harvested, cleared of periadvential fat and were handled carefully to preserve an intact endothelium. The aortic rings (4-5 mm) were kept in warmed (37°C) and gas-equilibrated (95% O 2 , 5% CO 2 ) Krebs solution containing: 1.6 mM CaCl 2 , 1.17 mm MgSO 4 , 26 µM EDTA, 130 mM NaCl, 14.9 mM NaHCO 3 , 4.7 mM KCl, 1.18 mM KH 2 PO 4 , and 11 mM glucose.
Vascular superoxide production
Lucigenin-amplified chemiluminescence assays. Each rat aorta segment was immersed in Krebs buffer at pH 7.40, for 20 min. The arterial segments were then rapidly transferred to a counting vial under light protection and immersed in a 5-µM lucigenin (Sigma, USA) solution in Krebs buffer (total volume = 1.0 mL). This lucigenin concentration is within the range proposed to be less likely to undergo redox cycling, reflecting, therefore, superoxide generation by tissues (5, 6) . The luminescence emitted by each fragment was measured for 5 min in a Berthold Multi Biolumat luminometer (Berthold, Germany). Background signals from buffer and lucigenin were subtracted from artery signals and the resulting value was normalized for dry weight. Data are reported as counts per min (cpm) per mg of dry tissue. Chemiluminescence was measured directly and continuously for 5 min to obtain basal values. Superoxide generation from rat aortic ring segments was obtained under several experimental conditions. To analyze the role of specific pathways, some compounds were added at the following final concentrations: 1) 1 mM L-NAME, 2) 10 µM reactive blue, 3) 1 µM pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS), 4) 0.1 mM 2-methylthioadenosine 5'-triphosphate (2MeSATP; a non-selective P2Y agonist), and 5) 30 µM β-γ-methylene-ATP (a partially selective P2X antagonist). After 5 min a new record of superoxide production was obtained. ATP was added at a final concentration of 0.1 mM, 10 min after addition of the compounds, and after 5 min a new record of superoxide production was obtained.
Vascular reactivity in isolated aortic rings
The thoracic aortas were mounted in organ baths filled with warm (37°C) and gas-equilibrated Krebs solution. Isometric tension was measured with isometric transducers (Biopac Systems, TSD105A, USA), digitized, stored, and displayed on a computer. The pre-load was 1.5 g and the solution was changed every 20 min within the first hour (22) . A dose-response curve for ATP (10 nM to 100 µM) was constructed after preconstriction with 0.1 µM norepinephrine. L-NAME was added to the bath solution to a final concentration of 1 mM and the aortic rings were pre-incubated for 15 min before the determination of the dose-response curve for ATP.
Nitrate content in the aorta
Harvested aortas were snap frozen in liquid nitrogen and then homogenized with a stainless steel mortar cooled in liquid nitrogen. Tissue dry powder was dissolved in Krebs solution and centrifuged at 1600 g for 5 min. The supernatant was then injected into the NO analyzer (Sievers Instrument, USA) for direct assessment of NO and metabolites. Nitrate content was normalized according to protein concentration in the extract and the amount of protein in tissue homogenates was assayed by the method of Bradford.
iNOS identification and quantification in aorta
RNA was extracted from aorta tissue with Trizol ® (Gibco-BRL, USA) according to manufacturer instructions. RT-PCR was performed using ImProm-II Reverse Transcriptase (Promega, USA) with 1 µg of total RNA as a template annealed with Oligo dT (Promega) for cDNA synthesis. This reaction was performed at 42°C for 50 min followed by 70°C for 15 min to inactivate the reverse transcriptase enzyme. For inducible NOS (iNOS) amplification, PCR was performed with 35 cycles of 94°C for 30 s, 92°C for 1 min, 63.5°C for 1 min, and 72°C for 1 min followed by a final extension for 10 min at 72°C. The following primers were used to amplify 170 bp for rat iNOS (Gen Bank accession No. D44591) forward primer: 5' CAC CTT GGA GTT CAC CCA GT 3' and reverse primer: 5' ACC ACT CGT ACT TGG GAT GC 3'. GAPDH was used as a housekeeping gene. The reactions were carried out in an MJ Research Thermal Cycler PTC 200 (USA). The products were electrophoresed on 1% agarose gel and visualized by ethidium bromide staining. Densitometry values were normalized to GAPDH expression using the ImageJ program and the quantity of mRNA was determined with the Genius Plus software (TECAN Austria GMBH, Austria).
Identification of the phosphorylated proteins: Akt and eNOS
Pulverized vessels were rehydrated with lysis buffer containing 20 mM HEPES, 150 mM NaCl, 1.5 mM MgCl 2 , 1.0 mM EGTA, 10% glycerol, 1% Triton, 1 µg/mL aprotinin, 1 µg/mL leupeptin, 1.0 mM PMSF and phosphatases inhibitors (2 mM sodium orthovanadate, 50 mM sodium fluoride, and 10 mM sodium pyrophosphate). Total protein concentration was determined with the Bio-Rad Protein Assay (Bio-Rad, USA). After heating at 100°C for 5 min, 50 µg protein under reduced conditions (phospho-Akt and β-actin antibodies) and under non-reduced conditions (eNOS and phospho-eNOS antibodies) were resolved by SDS-PAGE on a 10% gel and transferred to a nitrocellulose membrane. The nitrocellulose membranes were incubated in blocking buffer (TBS with 5% milk and 0.05% Tween 20) for 2 h at room temperature and then probed with mouse anti-eNOS (1:1000, Calbiochem, USA), mouse anti-phospho-eNOS (1:1000, Calbiochem), rabbit anti-phospho-Akt antibody (1:500, Santa Cruz Biotech, USA), and mouse anti-β-actin (1:10,000, Sigma-Aldrich, USA) overnight at 4°C. The membranes were then washed and incubated with horseradish peroxidase-conjugated goat anti-mouse IgG (1:2000 for eNOS, 1:2000 for phospho-eNOS, and 1:10,000 for β-actin; Calbiochem) or horseradish peroxidase-conjugated goat anti-rabbit IgG (1:1500 for phospho-Akt; Calbiochem). Proteins were visualized using the ECL Western Blotting Analysis System (GE Healthcare, USA).
Reagents
All chemicals were purchased from Sigma, except when otherwise stated.
Statistical analyses
Data are reported as means ± SEM in all figures. The Student t-test was used to compare two groups and ANOVA was used for three or more groups, followed by the Bonferroni post-test. The level of significance was set at P < 0.05.
Results

Endotoxemic aortic rings presented increased relaxation in response to ATP
Endothelium-dependent relaxation (acetylcholine) is impaired in endotoxemic animals (23) . We first determined whether aortic rings from LPS animals presented different relaxant responsiveness to ATP compared to control. There was a greater relaxation response to ATP in LPS animals vs control (106.72 ± 2.29 vs 100.15 ± 0.85%; P < 0.05; Figure 1 ).
ATP vasorelaxation is mediated by NOS
We used L-NAME (1 mM) in vitro during vascular reactivity procedures to determine the role of vascular NO production by ATP (10 nM to 100 µM). L-NAME inhibits NOS and is a useful tool employed to analyze if vasorelaxation is NO related. L-NAME almost completely blocked the relaxation response to ATP (Figure 2A ,B) in the aortas from both control and LPS-treated animals.
ATP decreases NOS superoxide production in sepsis
There was a significant increase of superoxide in aorta from LPS animals vs control (9424.6 ± 1098.9 vs 1212 ± 127.3 counts/mg aorta). ATP reduced superoxide release to 4769.7 ± 797.9 counts/mg dry aorta tissue in LPS-treated animals (P < 0.05; Figure 3) . NOS-dependent superoxide production was analyzed using the NOS inhibitor L-NAME, which reduced superoxide production by LPS aortic rings: 13,277 ± 695 counts/mg aorta for LPS vs 6614 ± 640 counts/mg aorta for LPS-L-NAME (P < 0.05; Figure 4 ). The superoxide release-reducing effect of ATP was completely blocked by L-NAME: 6614 ± 640 counts/mg aorta for LPS-L-NAME vs 6753 ± 525 counts/ mg aorta for LPS-L-NAME-ATP (P > 0.05; Figure 4) . A direct measurement of nitrate and iNOS in aortic rings was also conducted. The aortic rings taken from LPS animals showed a significantly higher peak of nitrate content (17.4 ± 3.5 vs 5.25 ± 0.4 µM/mg protein for LPS vs control; P < 0.05; Figure 5A ). iNOS expression analyzed by RT-PCR was also increased in LPS animals ( Figure 5B ).
The effect of ATP is mediated via P2Y
P2X and P2Y inhibitors were added to the bath solution and only the reactive blue P2Y inhibitor blocked the effect of ATP in reducing superoxide production (4129 ± 601 vs 3797 ± 946; P > 0.05; Figure 6 ), while the P2X inhibitor PPADS did not block the action of ATP (6078 ± 822 vs 3361 ± 438; P < 0.05; Figure 6 ). Different agonists were used to check and confirm the purinergic receptor. When 2MeSATP (a non-selective P2Y agonist) and β-γ-methylene ATP (partially selective P2X) were Effect of lipopolysaccharide (LPS) and ATP on superoxide production by aortic rings incubated ex vivo. Thoracic aortic rings were harvested from control rats or from experimental rats 16 h after LPS administration to measure superoxide production. ATP was added to the bath solution during incubation in order to obtain a 5-µM final concentration. Data are reported as means ± SEM for each experimental group containing 9 rats. + P < 0.05 for basal control vs basal LPS: a significant increase of superoxide production occurred compared to control animals; *P < 0.05 for basal LPS vs LPS plus ATP: a significant direct action of ATP reducing superoxide production in LPS-treated animals compared to baseline (ANOVA and Bonferroni's test). Effect of L-NAME on superoxide production by aorta incubated ex vivo. Thoracic aortic rings were harvested from rats 16 h after lipopolysaccharide (LPS) administration to measure superoxide production. Superoxide production was measured in the same aortic ring sequentially under three conditions: 1) basal; 2) L-NAME addition (1 mM); 3) followed by ATP addition (0.1 mM). Data are reported as means ± SEM for each experimental group containing 9 rats. *P < 0.05, significant decrease of superoxide production compared to basal LPS (ANOVA and Bonferroni's test). There was no decrease in superoxide production when LPS L-NAME was compared to LPS L-NAME plus ATP. incubated with aortic rings, only 2MeSATP reduced superoxide production (5537 ± 821 vs 4905 ± 946; P < 0.05), whereas β-γ-methylene ATP did not modify superoxide production (5402 ± 911 vs 5491 ± 735; Figure 6 ).
ATP increases aortic content of the phosphorylated proteins: Akt (p-Akt) and eNOS (p-eNOS)
The addition of ATP to the bath solution containing the aortic rings produced a transient increase in p-Akt ( Figure 7A,B) Figure 5. Nitric oxide production after lipopolysaccharide (LPS) administration. A, Nitrate concentration in aortic rings. There was a significant increase of nitrate content in the aorta after LPS administration. B, RT-PCR for inducible nitric oxide synthase (iNOS) expression in aortic rings. Data are reported as means ± SEM for each experimental group containing 6 rats. GAPDH = glyceraldehyde-3-phosphate dehydrogenase. There was an increased expression of iNOS after LPS injection compared with control animals. *P < 0.05 for control vs LPS (Student t-test) . Figure 6 . Effect of ATP, ATP agonists and inhibitors on superoxide production by aorta incubated ex vivo. Thoracic aortic rings were harvested from rats 16 h after LPS administration to measure superoxide production. The aorta was initially incubated without any compound to obtain a basal value (white columns). After 10 min, one of the following compounds was added: ATP (1 mM), 2MeSATP (0.1 mM -a nonselective agonist) or methylene-ATP (30 µM -a partially selective P2X). The inhibitors PPADS (1 µM) or RB (10 µM) were added to two sets of aortic rings to which ATP had been previously added. RB = reactive blue; PPADS = pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid; 2MeSATP = 2-methylthioadenosine 5'-triphosphate. Data are reported as means ± SEM for experimental group containing 9 rats. *P < 0.05, significant decrease of superoxide production compared to basal LPS (Student t-test). lasting 3 min and returning to basal levels thereafter. The increase in p-Akt was more intense in the LPS aorta group than in the control ( Figure 7B ). The presence of ATP induced an increase in the amount of p-eNOS in both the control and LPS groups ( Figure 7A,C) . The amount of total eNOS was lower in the LPS group than in the control group ( Figure 7C ).
Discussion
Sepsis is a well-known condition presenting an endothelium-dependent reduced vasorelaxation. Ex vivo experiments have demonstrated the loss of endothelial function in LPS-treated animals, as measured by the relaxant responsiveness of pre-contracted vascular rings to the endothelium-dependent vasodilator NO liberating the hormone acetylcholine. ATP is also known to induce NO synthesis and release; however, there are no studies of the vascular relaxant responsiveness to ATP of septic animals (10-13). The average concentration of nucleotides in plasma and in other extracellular fluids is generally in the 0.4-to 6-µM range (24) , and these values can increase at sites of vascular inflammation, ischemia and platelet degranulation (25) . Our data confirm that ATP produces vasorelaxation through NO release. Figure 2 shows that L-NAME inhibited aorta relaxation induced by ATP in both control and LPS animals. ATP induced greater relaxation compared to control a result that is opposite to the effect of acetylcholine (23) detected in endotoxemic animals. The effect of ATP in increasing vascular caliber improves the matching between oxygen supply and metabolic demand (26) .
In the present stud, the increased superoxide production in the aorta was followed by increased aortic nitrate content, iNOS mRNA expression, and increased amounts of nitrotyrosine in the aorta (data not shown). In various disease conditions, all types of NOS (neuronal, inducible, and endothelial) have been reported to generate oxidants through unknown mechanisms (27, 28) . The catalytic activity of eNOS is exquisitely sensitive to ONOO -, which decreases NO synthesis and increases superoxide anion (O 2
•-) production by the enzyme (29) . Hence, eNOS exposure to oxidants including ONOO -causes increased enzymatic uncoupling and generation of O 2
•-, further contributing to oxidant stress in endothelial cells (29) . In the LPS group, ATP not only increased vasorelaxation (Figure 1 ) but significantly decreased superoxide production ( Figure 3) . The reduction in superoxide production by ATP may explain the better vasorelaxation performance of septic aortic rings. In addition, we showed that L-NAME also reduced superoxide production, in agreement with literature reports that superoxide production by uncoupled NOS was blocked by L-NAME but not by apocynin (an NADPH oxidase inhibitor) (4,30). Next we checked the effect of ATP in the presence of L-NAME and we observed that the inhibitory effect of ATP on superoxide production was blocked by L-NAME. These data suggest that NOS activity was an important source of superoxide in the present study. In addition, the data suggest that the purinergic effect on superoxide production is related to the regulation of NOS activity. Therefore, the presence of ATP seems to reverse superoxide production by NOS and the NO release induced in septic aortas. Assays using different antagonists and agonists have confirmed that this effect is produced by purinergic activation. The action of ATP on superoxide production is due to the P2Y receptor, as confirmed by the experiments using agonists and antagonists the P2Y and P2X receptors. The P2Y receptors in endothelial cells (P2Y1, P2Y2, and P2Y11) are G protein-linked and activate the phosphoinositol system, leading to store-operated calcium influx after inositol (1,4,5) P3-induced release of calcium from intracellular stores and, in the case of P2Y11, are also linked to the cAMP/protein kinase A pathway.
We found a maximal increase in NO and O 2
•-production in the aorta 16 h after LPS administration, just when the vascular relaxation to acetylcholine was compromised (data not shown). Superoxide is an NO scavenger and rapidly reacts to form peroxynitrite (ONOO -) (31) . eNOS uncoupling, whereby eNOS generates O 2
•-rather than NO, is an important mechanism underlying endothelial dysfunction (4). Endothelial dysfunction in sepsis is associated with reduced NO bioactivity and increased O 2
•-production (4). Various studies have also shown that NOS may suffer oxidation during situations of intense oxidative stress, and this leads NOS to produce superoxide instead of NO (28, 29, 32) . Another explanation for this uncoupling is the oxidation of tetrahydrobiopterin, a critical cofactor for the NO synthases. When tetrahydrobiopterin is absent these enzymes become "uncoupled" (28, 33) . The production of reactive oxygen species (ROS) in blood vessels occurs from two main sources. An NADPH oxidase, similar to the neutrophil oxidase, is present in endothelial and vascular smooth muscle cells and seems to be a source of ROS (13) . In addition, the endothelial and neuronal NOS (eNOS and nNOS, respectively), both cytochrome p450 reductase-like enzymes (14) , can produce large amounts of ROS when deprived of their critical cofactor tetrahydrobiopterin or their substrate L-arginine (15) (16) (17) (18) (19) (20) (21) (22) .
Stimulation of astrocytic P2X7 receptors, as well as other P2 receptors, has been shown to induce Akt activation (34) . Extracellular ATP acting in part through Gi proteins increased PI3K activity in a time-dependent manner and a transient phosphorylation of Akt was produced (35) . Western blotting measurements showed that p-Akt and p-eNOS were induced by ATP (Figure 7) . The increase in the aorta content of p-eNOS occurred in both control and LPS animals. Although septic aortic rings showed a reduced amount of eNOS, ATP addition was effective in increasing the amount of p-eNOS. The eNOS enzyme has been shown to present higher activity when phosphorylated (36, 37) . In the present experiments, ATP increased p-eNOS while simultaneously reducing superoxide production. The superoxide production through NOS activity was confirmed in the experiments using L-NAME, an NOS inhibitor. Literature data regarding different cell lines have shown that Akt directly phosphorylates eNOS (4) . In order to check this pathway, in our study we showed that p-Akt was increased within a very short time after ATP stimulation. Akt may participate in the pathway inducing eNOS phosphorylation by ATP in LPS animals. A limitation of our study is that we did not check the effect of an Akt inhibitor on superoxide production and p-eNOS amount in order to confirm this pathway as determinant of the effects.
Normal vascular reactivity is a crucial factor in maintaining adequate blood perfusion. Septic vessels present severe functional impairment, which is associated with end-organ damage (38) . ATP is an endogenous substance eliciting endothelium-dependent vascular relaxation. Even in the presence of endothelial dysfunction ATP produces effective vascular relaxation. Through the property shown in the present study of reducing superoxide production and increasing or maintaining NO release in conditions of endothelial damage, ATP is able to sustain better vascular reactivity. These findings suggest a novel role for ATP in the endothelium under oxidative stress, i.e., the induction of eNOS phosphorylation that "recouples" NOS activity with a consequent reduction in superoxide production and with the occurrence of appropriate vasorelaxation. The development of compounds and drugs with an action based on purinergic activation would be highly desirable for the treatment of septic endothelial dysfunction.
